After a clean sweep of victories in the 2020 election in the United States, it looks like marijuana legalization is about to make big inroads across the globe as well with Mexico and Israel advancing towards ending prohibition.
Cannabis therapy mitigates symptoms of the chronic pain condition fibromyalgia and is associated with a reduction in the use of other prescription drugs, according to clinical data published online ahead of print in the Journal of Clinical Rheumatology. An estimated 3 to 6 million Americans are afflicted by fibromyalgia, which is often poorly controlled by standard pain medications.
Cannabis therapy is safe and effective among elderly patients diagnosed with chronic pain, according to clinical data published online ahead of print in the European Journal of Internal Medicine. “After six months of treatment, 93.7 percent of the respondents reported improvement in their condition,” researchers reported.
Australian lawmakers are anticipated to approve landmark legislation in the coming months allowing for the production and use of cannabis for therapeutic purposes. “This government understands that there are some Australians suffering from severe conditions for which cannabis may have applications,” Health Minister Sussan Ley told Parliament this week. “[W]e want to enable access to the most effective medical treatments available.”
Plenty of marijuana law reform legislation was introduced in state legislatures across the country this week! We have news out of Georgia, Kansas, Maryland, New Hampshire, Utah and Washington. Plus some news from abroad! Click here to get the latest news in marijuana law reform from this week.
The administration of liquid cannabis extracts containing THC is associated with the mitigation of various symptoms of Alzheimer’s-related agitation and dementia, according to observational trial data published online ahead of print in The Journal of Alzheimer’s Disease. Investigators concluded, “Adding medical cannabis oil to Alzheimer’s disease patients pharmacotherapy is safe and a promising treatment option.”
Inhaling cannabis is associated with the remission of refractory idiopathic angioedema, according to a clinical report published in the journal Case Reports in Immunology. Authors reported: “The use of inhaled cannabis resulted in a complete response, and he has been free of symptoms for 2 years.”